Latest filing published 07 Aug 2026 for AMGEN INC, €302k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Nancy A. Grygiel (senior executive) discloses dealings in Amgen Inc to SEC (Form 4). Over a trading history stretching from 30 April 2021 to 6 August 2026, the count stands at 45 filings.
No open-market purchase appears, only 8 sales worth €3.5M. The rest of the record consists of 33 share grants and 4 option exercises. So far in 2026, the count stands at no purchases and 3 sales.
The latest filing, published on 7 August 2026, reports an open-market sale of €685k in Amgen Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 45 declarations